126 related articles for article (PubMed ID: 17373959)
1. A Caucasian male with very low blood cholesterol and low apoA-II without evidence of atherosclerosis.
Park SH; Kim JR; Park JE; Cho KH
Eur J Clin Invest; 2007 Apr; 37(4):249-56. PubMed ID: 17373959
[TBL] [Abstract][Full Text] [Related]
2. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients.
Cho KH; Park SH; Park JE; Kim YO; Choi I; Kim JJ; Kim JR
Clin Biochem; 2008 Jan; 41(1-2):56-64. PubMed ID: 17996200
[TBL] [Abstract][Full Text] [Related]
3. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
Lee JH; Park JH; Lee SH; Kim JR; Cho KH
Int J Mol Med; 2010 Jun; 25(6):945-51. PubMed ID: 20428800
[TBL] [Abstract][Full Text] [Related]
4. Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apo A-II.
Atta M; Crook D; Shafique F; Johnston DG; Godsland IF
Thromb Haemost; 2008 Sep; 100(3):391-6. PubMed ID: 18766253
[TBL] [Abstract][Full Text] [Related]
5. Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity.
Park KH; Shin DG; Kim JR; Cho KH
J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):600-10. PubMed ID: 20421239
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.
Allayee H; Castellani LW; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2003 Jun; 92(11):1262-7. PubMed ID: 12738753
[TBL] [Abstract][Full Text] [Related]
7. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
Tian L; Wu J; Fu M; Xu Y; Jia L
Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
[TBL] [Abstract][Full Text] [Related]
8. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
[TBL] [Abstract][Full Text] [Related]
9. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L
Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773
[TBL] [Abstract][Full Text] [Related]
10. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
[TBL] [Abstract][Full Text] [Related]
11. A selective peroxisome proliferator-activated receptor δ agonist PYPEP suppresses atherosclerosis in association with improvement of the serum lipoprotein profiles in human apolipoprotein B100 and cholesteryl ester transfer protein double transgenic mice.
Naya N; Fukao K; Nakamura A; Hamada T; Sugimoto M; Kojima M; Yoshimura N; Uwabe K; Imagawa K; Nomura K; Hara S; Nakano T; Iwasaki T; Shinosaki T; Hanasaki K
Metabolism; 2016 Jan; 65(1):16-25. PubMed ID: 26683793
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein apolipoprotein A-I kinetics in obesity.
Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
Obes Res; 2005 Jun; 13(6):1008-16. PubMed ID: 15976143
[TBL] [Abstract][Full Text] [Related]
13. AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency.
Vaessen SF; Veldman RJ; Comijn EM; Snapper J; Sierts JA; van den Oever K; Beattie SG; Twisk J; Kuivenhoven JA
J Gene Med; 2009 Aug; 11(8):697-707. PubMed ID: 19431216
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of high density lipoprotein apolipoprotein A-I and cholesteryl ester in insulin resistant dog: a stable isotope study.
Briand F; Bailhache E; Nguyen P; Krempf M; Magot T; Ouguerram K
Diabetes Obes Metab; 2007 Jan; 9(1):139-42. PubMed ID: 17199733
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
[TBL] [Abstract][Full Text] [Related]
16. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
17. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
Moradi H; Pahl MV; Elahimehr R; Vaziri ND
Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization.
Li CM; Chung BH; Presley JB; Malek G; Zhang X; Dashti N; Li L; Chen J; Bradley K; Kruth HS; Curcio CA
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2576-86. PubMed ID: 15980251
[TBL] [Abstract][Full Text] [Related]
19. [The interrelationships between serum triglyceride, total cholesterol and HDL subpopulations].
Yan BY; Fu MD; Yang YY; Xu YH; Liu Y; Yang LC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):327-9. PubMed ID: 15181826
[TBL] [Abstract][Full Text] [Related]
20. Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase.
Salvatore A; Cigliano L; Bucci EM; Corpillo D; Velasco S; Carlucci A; Pedone C; Abrescia P
Biochemistry; 2007 Oct; 46(39):11158-68. PubMed ID: 17824618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]